The glucagon-like peptide-1 receptor agonist reduces inflammation and blood-brain barrier breakdown in an astrocyte-dependent manner in experimental stroke. [electronic resource]
Producer: 20200514Description: 242 p. digitalISSN:- 1742-2094
- Animals
- Astrocytes -- drug effects
- Blood-Brain Barrier -- drug effects
- Chemokine CCL2 -- metabolism
- Chemokine CXCL1 -- metabolism
- Exenatide -- pharmacology
- Infarction, Middle Cerebral Artery -- metabolism
- Inflammation -- drug therapy
- Male
- Matrix Metalloproteinase 9 -- metabolism
- Rats
- Rats, Sprague-Dawley
- Stroke -- metabolism
- Vascular Endothelial Growth Factor A -- metabolism
- Glucagon-Like Peptide-1 Receptor Agonists
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.